2020
DOI: 10.1016/j.xjtc.2020.05.015
|View full text |Cite
|
Sign up to set email alerts
|

Extracorporeal support to treat E-cigarette or vaping product use-associated lung injury (EVALI) during the coronavirus disease 2019 (COVID-19) pandemic

Abstract: See Commentaries on pages 385 and 387.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Several factors made collection of additional cases challenging. First, the peak of EVALI coincided with the beginning of the COVID-19 pandemic, absorbing an incredible amount of bandwidth from the pulmonary, critical care, and ECLS clinical and research infrastructure universally (4, 41). Second, cross-country and cross-institutional collaboration, while extremely valuable, can be difficult from a legal and data-use agreement standpoint, and, unfortunately, a few investigators who were willing to collaborate were unable to gain institutional approval (42).…”
Section: Discussionmentioning
confidence: 99%
“…Several factors made collection of additional cases challenging. First, the peak of EVALI coincided with the beginning of the COVID-19 pandemic, absorbing an incredible amount of bandwidth from the pulmonary, critical care, and ECLS clinical and research infrastructure universally (4, 41). Second, cross-country and cross-institutional collaboration, while extremely valuable, can be difficult from a legal and data-use agreement standpoint, and, unfortunately, a few investigators who were willing to collaborate were unable to gain institutional approval (42).…”
Section: Discussionmentioning
confidence: 99%
“…In this issue of the Journal , Hayanga and colleagues 3 reported a complex case of ALI during the early phase of the COVID-19 pandemic. A 30-year-old woman at 33 weeks of gestation, with a high index of suspicion for SARS-CoV-2 infection, presented with a rapidly progressive severe hypoxic ALI refractory to maximal therapy.…”
mentioning
confidence: 99%
“…Amid the new “clinical normal” imposed by the COVID-19 pandemic, the case report by Hayanga and colleagues 3 illustrates that cardiac surgeons, who remain the gatekeepers of mechanical circulatory support in most hospital systems, must remain sensitive to the panoply of causes of severe respiratory failure requiring veno-venous ECMO. An emerging indication, unfortunately obscured by the overwhelming global catastrophe of COVID-19, is vaping and e-cigarette–induced ALI, and must be evaluated in the differential diagnosis of severe refractory respiratory failure, even in patients with a high probability of exposure to SARS-CoV-2.…”
mentioning
confidence: 99%
“…In their article in this issue of JTCVS Techniques, Hayanga and colleagues 8 apply many of the aforementioned principles, including preparedness drills using high-fidelity scenarios with mock pumps and mannequins. This allowed for a reproducible response of all team members and procedures and also identified holes that otherwise might have been Through preparedness and practice, the ability to expeditiously put COVID patients on extracorporeal membrane oxygenation while keeping staff safe allows for the swift treatment of patients before a diagnosis is known.…”
mentioning
confidence: 99%